DYNLL2

Dynein light chain 2, cytoplasmic · Q96FJ2 · DYNLL2 on Sugi Atlas →

0 patent compounds predicted against DYNLL2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DYNLL2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Biologic Correlative Taxotere/AC PHASE2COMPLETED
Study of ABT-751 in Patients With Refractory Hematologic Malignancies PHASE1COMPLETED
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype EARLY_PHASE1COMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Early Detection and Characterization of Primary Ciliary Dyskinesia nanUNKNOWN
Mapping Disease Pathways for Biliary Atresia nanRECRUITING
PCD New Gene Discovery nanCOMPLETED
NIOX VERO Nasal Application in Primary Ciliary Dyskinesia nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Characteristics of Nondystrophic Myotonias nanCOMPLETED
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia nanUNKNOWN
Positional Cloning of the Gene(s) Responsible for Alagille Syndrome nanCOMPLETED
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Core Stability Exercises and Hereditary Ataxia nanCOMPLETED
Genetics of Familial and Sporadic ALS nanCOMPLETED
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Diagnostic of Chemotherapy Induced Neuropathy in Children nanCOMPLETED
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a DYNLL2 binder may also engage these)

ProteinNameSimilarity
Q9D0M5 1.000 Q9D0M5 →
Q24117 1.000 Q24117 →
DYNLL1 Dynein light chain 1, cytoplasmic 1.000 landscape →
P63168 1.000 P63168 →
P63169 1.000 P63169 →
P61285 1.000 P61285 →
O96860 1.000 O96860 →
P61273 1.000 P61273 →
Q22799 1.000 Q22799 →
O02414 1.000 O02414 →
P63170 1.000 P63170 →
Q39580 1.000 Q39580 →
Q3MHR3 1.000 Q3MHR3 →
Q78P75 1.000 Q78P75 →
Q94748 0.994 Q94748 →
Q94758 0.991 Q94758 →
Q9UR05 0.989 Q9UR05 →
O94111 0.988 O94111 →
Q759T0 0.985 Q759T0 →
Q86A88 0.984 Q86A88 →
Q02647 0.980 Q02647 →
Q6CWX4 0.978 Q6CWX4 →
Q6BZF8 0.978 Q6BZF8 →
Q6FUJ0 0.975 Q6FUJ0 →
A4VE64 0.972 A4VE64 →
Q5XHY5 0.967 Q5XHY5 →
O77210 0.965 O77210 →
P08418 0.964 P08418 →
Q3ZBV8 0.964 Q3ZBV8 →
P26413 0.964 P26413 →